Everything you need to win Ziad Rouag — in one platform.
Who to reach, what to say, and why now on Ziad Rouag — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Ziad Rouag — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Endra Life Sciences Inc. Appoints Alexander Tokman As Acting Chief Executive Officer and Adds Ziad Rouag As Head of Regulatory and Clinical Affairs and Richard Jacroux As Chief Financial Officer
PUBLIC · NDRAAug 13, 2024•almost 2 years ago
Position
Head of Regulatory and Clinical Affairs
Company
ENDRA Life Sciences
Ziad Rouag
Ann ArborManufacturingHealth Care
Description
ENDRA Life Sciences Inc. announced the appointment of Alexander Tokman as acting Chief Executive Officer to replace Francois Michelon, who stepped down from his role as Chief Executive Officer and as a member of the Board of Directors. Additionally, the Company added Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer.
Company Information
Company
ENDRA Life Sciences
Location
Ann Arbor, Michigan, United States
About
ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD).
Ann ArborManufacturingHealth Care